In cancer CD30 is most consistently expressed by Reed-Sternberg cells of Hodgkins lymphoma and a group of neoplasms known as anaplastic large cell lymphoma (ALCL), making it a relatively specific target for immunotherapy [1], [2]. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.